1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. BB Biotech AG
  6. News
  7. Summary
    BION   CH0038389992

BB BIOTECH AG

(BION)
  Report
Real-time Estimate Cboe Europe  -  05/17 10:08:28 am EDT
56.25 CHF   +1.17%
04/22BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/22BB Biotech Swings To Q1 Loss As Total Returns Plummet
MT
04/22BB Biotech AG publishes its interim report
EQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

BB Biotech Ag Announces Board Changes

07/23/2021 | 01:00am EDT

BB Biotech AG announced that Dr. Susan Galbraith will resign from the Board of Directors of the company with immediate effect.


ę S&P Capital IQ 2021
All news about BB BIOTECH AG
04/22BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/22BB Biotech Swings To Q1 Loss As Total Returns Plummet
MT
04/22BB Biotech AG publishes its interim report
EQ
04/22BB BIOTECH AG : Increased investment level balanced by established core holdings
EQ
04/12GLOBAL MARKETS LIVE : Honda, Shopify, Meta, ASOS, Gilead Sciences...
04/12BB Biotech Launches New Share Repurchase Program
MT
04/12BB Biotech AG concludes its share buyback program and launches a new buyback program
EQ
04/12Tranche Update on BB Biotech AG’s Equity Buyback Plan announced on April 11, 2019.
CI
04/12BB Biotech AG authorizes a Buyback Plan.
CI
04/12BB Biotech AG announces an Equity Buyback.
CI
More news
Analyst Recommendations on BB BIOTECH AG
More recommendations
Financials
Sales 2022 796 M 792 M 792 M
Net income 2022 497 M 495 M 495 M
Net Debt 2022 278 M 277 M 277 M
P/E ratio 2022 4,19x
Yield 2022 7,27%
Capitalization 3 065 M 3 053 M 3 053 M
EV / Sales 2022 4,20x
EV / Sales 2023 5,01x
Nbr of Employees 10
Free-Float 98,1%
Chart BB BIOTECH AG
Duration : Period :
BB Biotech AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BB BIOTECH AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 4
Last Close Price 55,60 CHF
Average target price 75,13 CHF
Spread / Average Target 35,1%
EPS Revisions
Managers and Directors
Michael Hutter Head-Finance & Compliance
Erich Hunziker Chairman-Supervisory Board
Daniel Koller Head-Investment Management
Clive A. Meanwell Vice Chairman-Supervisory Board
Thomas von Planta Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BB BIOTECH AG-27.93%3 053
MODERNA, INC.-46.35%54 199
LONZA GROUP AG-28.13%40 453
IQVIA HOLDINGS INC.-26.83%39 077
SEAGEN INC.-7.80%26 238
ICON PUBLIC LIMITED COMPANY-32.02%17 114